The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.


Updates from The Motley Fool

Latest updates on Allergan from Fool.com.  The Fool has written over 200 articles on Allergan.
4 Stocks We Would Never Sell

Image source: Getty Images. "You only have to do a very few things right in your life so long as ...

3 Stocks Billionaires Are Buying

Image source: The Motley Fool. Billionaire investors Warren Buffett, George Soros, and Carl Icahn...

Rumors Swirl Around Biogen Today

Image source: Stockmonkeys.com via Flickr. Fresh on the heels of reporting success in a late-stag...

1 Stock to Invest in Big Pharma

Image source: Getty Images. Over the past several years, the pharmaceutical industry as a whole s...

5 Stocks Hedge Funds Love

Image source: Google.com Hedge funds have underperformed the market in recent quarters. The HFRI...

8 Top Stocks Billionaires Love

Google's parent company, Alphabet, is a popular billionaire stock pick. Image source: Google. Inv...



Stock Performance

View Interactive AGN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Allergan.
Current Price: $192.25
Prev Close: $188.47
Open: $189.31
Bid: $192.42
Ask: $194.95
Day's Range: $189.13 - $196.30
52wk Range: $184.50 - $317.48
Volume: 5,377,630
Avg Vol 6,509,159
Market Cap: $76B
P/E (ttm): 13.80
EPS (ttm): $13.66
Div & Yield: $0.00 (1.5%)

Company Rating

What our community thinks about Allergan.
CAPS Rating 4 out of 5
 
427 Outperform
28 Underperform
CAPS All Stars
 
105 Outperform
6 Underperform

How do you think Allergan will perform against the market?



You pick for Allergan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Brenton Saunders, CEO

70% Approve

Based on 72 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Allergan.

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers